(Q38023235)

27 August 2017

title

The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care (English)

1 reference

27 August 2017

1 reference

Katherine Samaras

1

1 reference

27 August 2017

publication date

1 September 2012

1 reference

27 August 2017

published in

Current HIV/AIDS reports

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

206-217

1 reference

Diagnosis and classification of diabetes mellitus

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Incident hyperglycaemia among older adults with or at-risk for HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Disorders of glucose metabolism among HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Case-control study of diabetes mellitus in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Management of fat accumulation in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The impact of HIV/AIDS on Type 2 diabetes prevalence and diabetes healthcare needs in South Africa: projections for 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Lipid metabolism in treated HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Standards of medical care in diabetes--2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Assessment of the quality of diabetes care for HIV-infected patients in a national health care system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

HIV infection, aging and cardiovascular disease: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Elevated triglycerides and risk of myocardial infarction in HIV-positive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Prevalence of diabetes mellitus, hyperinsulinaemia and metabolic syndrome among 755 adult patients with HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0124-X

Disorders of fat partitioning in treated HIV-infection

21 January 2018

1 reference

12 December 2020

Small Dense Lipoproteins, Apolipoprotein B, and Risk of Coronary Events in HIV-Infected Patients on Antiretroviral Therapy

1 reference

12 December 2020

Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study

1 reference

12 December 2020

Increased prevalence of albuminuria in HIV-infected adults with diabetes

1 reference

12 December 2020

Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors

1 reference

12 December 2020

Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors

1 reference

12 December 2020

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection

1 reference

12 December 2020

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study

1 reference

12 December 2020

Severe diabetes associated with protease inhibitor therapy

1 reference

12 December 2020

The heart of the matter: cardiometabolic care in youth with psychosis.

1 reference

12 December 2020

Protease inhibitor-associated hyperglycaemia

1 reference

12 December 2020

New-onset diabetes mellitus associated with use of protease inhibitor

1 reference

12 December 2020

10.1007/S11904-012-0124-X

Identifiers

DOI

1 reference

27 August 2017

1 reference